Compass Therapeutics, Inc. (CMPX) Reports In-Line Q1 EPS

Compass Therapeutics, Inc. (NASDAQ: CMPX) reported Q1 EPS of ($0.10), in-line with the analyst estimate of ($0.10).

For earnings history and earnings-related data on Compass Therapeutics, Inc. (CMPX) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• SanDisk and Micron surge as Apple confirms memory price pass-through
• BNP Paribas Exane Upgrades Holcim Ltd (HOLN:SW) to Outperform